The effectiveness of butorphanol infusion in patients undergoing awake fibreoptic nasal intubtion: a randomized controlled trial.

The effectiveness of butorphanol infusion in patients undergoing awake fibreoptic nasal intubtion

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033607

Enrollment

Unknown

Registered

2020-06-06

Start date

2020-06-30

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia

Interventions

control group:Normal saline

experimental group:Butophanol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. ASA grade I~II; 2. Aged 18~65 years; 3. 30Kg/m2 >= BMI > 18Kg/m2; 4. Patients undergoing awake fibreoptic nasal intubtion; 5. Agree to participate in experimental observation and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Coagulation disorder; 2. Intracranial hypertension; 3. Fracture of nasal bone and skull base.

Design outcomes

Primary

Measure	Time frame
Bp;heart rate;	—

Secondary

Measure	Time frame
Ramsay Score;intubation time;adverse effect;satistaction score;	—

Countries

China

Contacts

Public ContactHu Tingju

Affiliated Hospital of GuiZhou Medical University

363818952@qq.com+86 18798000325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026